Dafalgan Codeine


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 30.8%
Product Used For Unknown Indication 15.4%
Back Pain 8.5%
Hypertension 6.0%
Depression 5.1%
Pain 3.8%
Analgesic Therapy 3.4%
Musculoskeletal Pain 3.0%
Oedema Peripheral 2.6%
Atrial Fibrillation 2.1%
Dyslipidaemia 2.1%
Essential Tremor 2.1%
Insomnia 2.1%
Pemphigoid 2.1%
Type 2 Diabetes Mellitus 2.1%
Anaemia 1.7%
Antiphospholipid Syndrome 1.7%
Malaise 1.7%
Mitral Valve Incompetence 1.7%
Myalgia 1.7%
Vomiting 16.7%
Transaminases Increased 11.9%
Somnolence 9.5%
Pyrexia 7.1%
Renal Failure 7.1%
Aortic Valve Disease 4.8%
Hepatitis 4.8%
Neutropenia 4.8%
Stevens-johnson Syndrome 4.8%
Thrombocytopenia 4.8%
Arthralgia 2.4%
Cytolytic Hepatitis 2.4%
Drug Dependence 2.4%
Hyperbilirubinaemia 2.4%
Hypokalaemia 2.4%
Malaise 2.4%
Off Label Use 2.4%
Polyarthritis 2.4%
Premature Baby 2.4%
Rash 2.4%
Concomitant
Product Used For Unknown Indication 16.2%
Drug Use For Unknown Indication 16.0%
Crohn's Disease 15.5%
Rheumatoid Arthritis 13.9%
Pain 6.5%
Hiv Infection 4.5%
Back Pain 3.3%
Breast Cancer Metastatic 3.3%
Osteoporosis 2.7%
Prophylaxis 2.7%
Ankylosing Spondylitis 2.2%
Essential Hypertension 2.0%
Hypertension 1.8%
Pulmonary Embolism 1.6%
Colorectal Cancer Metastatic 1.4%
Constipation 1.4%
Arthralgia 1.2%
Cardiac Disorder 1.2%
Chronic Obstructive Pulmonary Disease 1.2%
Oesophageal Carcinoma 1.2%
Renal Failure Acute 10.8%
Pyrexia 7.7%
Thrombocytopenia 7.7%
Erysipelas 6.2%
Gamma-glutamyltransferase Increased 6.2%
Renal Failure 6.2%
Vena Cava Thrombosis 6.2%
Anal Abscess 4.6%
Hyperkalaemia 4.6%
Meningioma 4.6%
Perineal Abscess 4.6%
Septic Shock 4.6%
Toxic Skin Eruption 4.6%
Anastomotic Fistula 3.1%
Atrioventricular Block Complete 3.1%
Basal Cell Carcinoma 3.1%
Encephalopathy 3.1%
Fracture Nonunion 3.1%
Hyponatraemia 3.1%
Nausea 3.1%

Drug Data